Build the in-house marketing function as Xeltis takes aXess™, our CE-marked vascular access platform, to physicians across Europe. First marketing hire, growth path attached. Why this role exists On 30 June 2026, Xeltis goes commercial. After more than a decade of development, multiple clinical trials, and CE Mark approval for aXess™, our vascular access platform for hemodialysis, we begin the first commercial launch in the company’s history. You will be joining Xeltis at the moment the…

Xeltis is a medical device company developing the world’s most advanced polymer-based platform of restorative cardiovascular devices. Our devices naturally evolve into living blood vessels within the body through the patient’s own tissue.

We recently received CE Mark approval for aXess™, our vascular access platform for hemodialysis patients, and are entering early commercial launch across key European sites. Multiple clinical trials are ongoing. We are a team of 60+ people from across the world, headquartered at the High Tech Campus in Eindhoven, the Netherlands.

Improving patients’ lives is what we do. We work on something that matters, and we work like we mean it.